# FDA Inspection 1180193 - Vitalant - September 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/vitalant/6f3aa6bd-abdc-4fc8-bfe4-2ca087b69914
Source feed: FDA_Inspections

> FDA Inspection 1180193 for Vitalant on September 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180193
- Company Name: Vitalant
- Inspection Date: 2022-09-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1256872 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/vitalant/f1a5fc9c-44dc-4e92-99a9-97678a82dacb)
- [FDA Inspection 1256872 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/vitalant/f423f9d9-0ae8-4e0f-9336-473f10176f3f)
- [FDA Inspection 1033943 - 2017-11-28](https://www.keypedia.com/records/fda_inspections/vitalant/eb113479-a5b2-443d-96f6-8110e46a25a9)
- [FDA Inspection 958203 - 2016-01-25](https://www.keypedia.com/records/fda_inspections/vitalant/6fbb82a1-0be3-4bf1-b94c-fb9b42394c13)
- [FDA Inspection 858500 - 2013-12-09](https://www.keypedia.com/records/fda_inspections/vitalant/25f79a2d-224f-4b73-92b7-6586f5b44734)

Company: https://www.keypedia.com/companies/vitalant/96cef0a4-a35a-4fdf-aec9-4a7559868eb0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d